|
Atomistry » Fluorine » PDB 4c6l-4cqj » 4ccb | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Fluorine » PDB 4c6l-4cqj » 4ccb » |
Fluorine in PDB 4ccb: Structure of the Human Anaplastic Lymphoma Kinase in Complex with 3-((R)-1-(5-Fluoro-2-(2H-1,2,3-Triazol-2-Yl) Phenyl)Ethoxy)-5-(5-Methyl-1H-Pyrazol-4-Yl)Pyridin-2-AmineEnzymatic activity of Structure of the Human Anaplastic Lymphoma Kinase in Complex with 3-((R)-1-(5-Fluoro-2-(2H-1,2,3-Triazol-2-Yl) Phenyl)Ethoxy)-5-(5-Methyl-1H-Pyrazol-4-Yl)Pyridin-2-Amine
All present enzymatic activity of Structure of the Human Anaplastic Lymphoma Kinase in Complex with 3-((R)-1-(5-Fluoro-2-(2H-1,2,3-Triazol-2-Yl) Phenyl)Ethoxy)-5-(5-Methyl-1H-Pyrazol-4-Yl)Pyridin-2-Amine:
2.7.10.1; Protein crystallography data
The structure of Structure of the Human Anaplastic Lymphoma Kinase in Complex with 3-((R)-1-(5-Fluoro-2-(2H-1,2,3-Triazol-2-Yl) Phenyl)Ethoxy)-5-(5-Methyl-1H-Pyrazol-4-Yl)Pyridin-2-Amine, PDB code: 4ccb
was solved by
M.Mctigue,
Y.Deng,
W.Liu,
A.Brooun,
A.Stewart,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Structure of the Human Anaplastic Lymphoma Kinase in Complex with 3-((R)-1-(5-Fluoro-2-(2H-1,2,3-Triazol-2-Yl) Phenyl)Ethoxy)-5-(5-Methyl-1H-Pyrazol-4-Yl)Pyridin-2-Amine
(pdb code 4ccb). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total only one binding site of Fluorine was determined in the Structure of the Human Anaplastic Lymphoma Kinase in Complex with 3-((R)-1-(5-Fluoro-2-(2H-1,2,3-Triazol-2-Yl) Phenyl)Ethoxy)-5-(5-Methyl-1H-Pyrazol-4-Yl)Pyridin-2-Amine, PDB code: 4ccb: Fluorine binding site 1 out of 1 in 4ccbGo back to Fluorine Binding Sites List in 4ccb
Fluorine binding site 1 out
of 1 in the Structure of the Human Anaplastic Lymphoma Kinase in Complex with 3-((R)-1-(5-Fluoro-2-(2H-1,2,3-Triazol-2-Yl) Phenyl)Ethoxy)-5-(5-Methyl-1H-Pyrazol-4-Yl)Pyridin-2-Amine
Mono view Stereo pair view
Reference:
Q.Huang,
T.W.Johnson,
S.Bailey,
A.Brooun,
K.D.Bunker,
B.J.Burke,
M.R.Collins,
A.Cook,
J.J.Cui,
K.N.Dack,
J.G.Deal,
Y.Deng,
D.M.Dinh,
L.D.Engstrom,
M.He,
J.Hoffman,
R.L.Hoffman,
H.Shen,
P.Johnson,
R.S.Kania,
H.Lam,
J.L.Lam,
P.Le,
Q.Li,
L.Lingardo,
W.Liu,
M.West Lu,
M.A.Mctigue,
C.L.Palmer,
P.F.Richardson,
N.W.Sach,
T.Smeal,
G.L.Smith,
A.E.Stewart,
S.L.Timofeevski,
K.Tsaparikos,
H.Wang,
H.Zhu,
J.Zhu,
H.Y.Zou,
M.Edwards.
The Design of Potent and Selective Inhibitors to Overcome Clinical Alk Mutations Resistant to Crizotinib. J.Med.Chem. V. 57 1170 2014.
Page generated: Thu Aug 1 00:42:00 2024
ISSN: ISSN 0022-2623 PubMed: 24432909 DOI: 10.1021/JM401805H |
Last articlesZn in 9JYWZn in 9IR4 Zn in 9IR3 Zn in 9GMX Zn in 9GMW Zn in 9JEJ Zn in 9ERF Zn in 9ERE Zn in 9EGV Zn in 9EGW |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |